徐农 - Zhejiang University School of Medicine

基本信息

浏览量：36

职业迁徙

个人简介

浙江大学医学院硕士毕业。从事肿瘤内科临床研究29年。曾在浙江省肿瘤工作16年，2001年调至浙医一院并组建化疗科。1999年在澳大利亚布里斯班Mater医院接受肿瘤学职业培训和临床进修。2002年在上海复旦大学接受全国GCP培训获临床试验资格证书。2005年ASCO Multidisciplinary Cancer Management Course（MCMC）培训，中国西安。

研究兴趣

论文共 278 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Molecular Subtyping and Precision Medicine in Triple-Negative Breast Cancer---based on Fudan TNBC Classification

Lijuan Weng,Jianliang Zhou,Shenchao Guo,Nong Xu,Ruishuang Ma

Cancer cell internationalno. 1 (2024): 120-120

引用0浏览0WOS引用

New Techniques to Identify the Tissue of Origin for Cancer of Unknown Primary in the Era of Precision Medicine: Progress and Challenges

Wenyuan Ma,Hui Wu,Yiran Chen,Hongxia Xu,Junjie Jiang,Bang Du,Mingyu Wan,Xiaolu Ma,Xiaoyu Chen,Lili Lin,Xinhui Su,Xuanwen Bao,Yifei Shen,Nong Xu,Jian Ruan,Haiping Jiang,Yongfeng Ding

BRIEFINGS IN BIOINFORMATICSno. 2 (2024)

引用0浏览0WOS引用

Updated Safety and Antitumor Activity of BB-1701 from Study 101 in the Multiple Dose Level Cohort of Patients with Locally Advanced/metastatic HER2-low Expressing Breast Cancer

Fei Ma, Xiaoxiang Guan,Jingfen Wang,Herui Yao,Xian Wang,Erika P. Hamilton,Yehui Shi,Xinjun Liang,Nong Xu, Huoling Tang, Xiangzhu Tian, Yuhong Zhou,Ziping Wei,Pamela N. Munster

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Phase 1b/2 Study of Penpulimab (AK105), an Antiprogrammed Cell Death-1 Immunoglobulin G1 Antibody, in Advanced or Metastatic Solid Tumors (AK105-204)

Yulong Zheng,Jianqing Zhu,Jianping Xiong,Ou Jiang,Hong Wang,Yanru Xie,Yuefen Zhou,Nong Xu

CANCERno. 12 (2024): 2180-2190

引用0浏览0WOS引用

Abstract RF02-05: Report on Cohort Expansion of Phase I Study to Investigate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of BB-1701 in Patients with Locally Advanced/Metastatic HER2 Low Breast Cancer

Fei Ma,Pamela Munster, Xiaoxiang Guan,Jingfen Wang,Herui Yao, Erika Hamilton,Xian Wang,Yehui Shi,Xinjun Liang,Nong Xu, Huoling Tang, Yuhong Zhou,Ziping Wei

Cancer Researchno. 9_Supplement (2024): RF02-05

引用0浏览0引用

Integrating Pathomics and Radiomics for Predicting Survival among Patients with Intrahepatic Cholangiocarcinoma Undergoing Surgical Resection

Mingyu Wan,Yifei Shen,Nong Xu,Jian Ruan

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Cadonilimab with Chemotherapy in HER2-negative Gastric or Gastroesophageal Junction Adenocarcinoma: the Phase 1b/2 COMPASSION-04 Trial

NATURE MEDICINE (2024)

引用0浏览0WOSNATURE引用

First-in-class PD-1/IL-2 Bispecific Antibody Fusion Protein IBI363 in Patients with Advanced Colorectal Cancer: Safety and Efficacy Results from a Phase I Study

Xueli Bai, Qin Xu,Xinjun Liang,Qian Chu,Xiaochen Zhang,Yiwen Chen,Nong Xu,Weijia Fang,Jianzhen Shan,Weiqin Jiang,Jianya Zhou,Yu-Long Zheng, Sixiang Long,Haonan Chen, Li Zhao,Hongli Wang,Jiya Sun,Xing Sun,Hui Zhou,Tingbo Liang

Journal of Clinical Oncologyno. 16_suppl (2024): 3593-3593

引用0浏览0引用

White Blood Cell Kinetics in Patients with Gynecologic Cancer Receiving Mecapegfilgrastim Prophylaxis: A Multicenter Real-World Study

Yong Chen, Liang Chen, Gang Li,Li Zuo, Gang Cheng,Nong Xu, Chenyu Mao, Peng Shen, Minbin Chen,Yanhong Wang, Zhanggui Wang, Rusen Zhao, Jun Bie, Weie Zheng,Haijiao Yan, Guifang Zhang, Zhe Yang,Ningling Zhang,Rui-Hua Xu, Xin Huang

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

First-line Osemitamab (TST001) Plus Nivolumab and Capox for Advanced G/gej Cancer (transtar102): Results of Cohort G from a Phase I/IIa Study

Xiaotian Zhang,Zengqing Guo,Jingdong Zhang, Weijian Guo, Meili Sun,Nong Xu, Charlie Qi, Xuelian Zhu,Lijuan Zhang, Xueming Qian, Caroline Germa,Lin Shen

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

Nong Xu(徐农)

主任医师

论文共 278 篇作者统计合作学者相似作者